➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Merck
Colorcon
Moodys
Harvard Business School
Mallinckrodt

Last Updated: August 5, 2020

DrugPatentWatch Database Preview

PITOCIN Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Pitocin, and what generic alternatives are available?

Pitocin is a drug marketed by Par Sterile Products and is included in one NDA.

The generic ingredient in PITOCIN is oxytocin. There are eleven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the oxytocin profile page.

US ANDA Litigation and Generic Entry Outlook for Pitocin

A generic version of PITOCIN was approved as oxytocin by WEST-WARD PHARMS INT on January 10th, 2007.

  Start Trial

Drug patent expirations by year for PITOCIN
Drug Prices for PITOCIN

See drug prices for PITOCIN

Recent Clinical Trials for PITOCIN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Wake Forest University Health SciencesPhase 2
San Francisco VA Health Care SystemPhase 2
VA Office of Research and DevelopmentPhase 2

See all PITOCIN clinical trials

Pharmacology for PITOCIN

US Patents and Regulatory Information for PITOCIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Par Sterile Products PITOCIN oxytocin INJECTABLE;INJECTION 018261-001 Approved Prior to Jan 1, 1982 AP RX Yes Yes   Start Trial   Start Trial   Start Trial
Par Sterile Products PITOCIN oxytocin INJECTABLE;INJECTION 018261-002 Jul 27, 2007 AP RX Yes No   Start Trial   Start Trial   Start Trial
Par Sterile Products PITOCIN oxytocin INJECTABLE;INJECTION 018261-003 Sep 5, 2012 RX Yes No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Merck
McKinsey
Johnson and Johnson
Colorcon
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.